MapLight Therapeutics, Inc. MPLT
$27.32
▼ -8.57% 24H
About
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) disorders. Its primary focus is on discovering and advancing circuit-specific treatments designed to address severe and difficult-to-treat brain conditions such as schi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees133
TickerMPLT
Statistics
Market Cap$1.23B
Revenue (TTM)—
Net Income-$161.2M
Net Margin—
EPS$-18.56
P/E-1.49
P/S—
P/B3.14
EV/EBITDA-4.56
ROE-81.0%
Dividend Yield—
Price$27.32
Data: Twelve Data · Revenue = mcap / P/S